Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Early research (Phase 1)Study completedNCT00019110What this trial is testingVaccine Therapy in Treating Patients With Advanced or Recurrent CancerWho this might be right forAnal CancerCervical CancerEsophageal Cancer+3 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07815197What this trial is testingSacituzumab Tirumotecan as Second-Line Treatment for Penile CancerWho this might be right forPenile Squamous Cell CarcinomaMetastatic Penile Squamous Cell Carcinoma Latin American Cooperative Oncology Group 37
Testing effectiveness (Phase 2)Looking for participantsNCT06161532What this trial is testingSacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C...Who this might be right forSmall Cell Carcinoma of the BladderSmall Cell Carcinoma of the Urinary TractSquamous Cell Carcinoma of the Bladder+5 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT03221400What this trial is testingPEN-866 in Patients With Advanced Solid MalignanciesWho this might be right forCarcinomaEndometrial AdenocarcinomaNeoplasms+16 more Tarveda Therapeutics 340
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06505551What this trial is testingPhase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive CarcinomaWho this might be right forHPV-Related Squamous Cell CarcinomaHPV-Related Cervical Squamous Cell CarcinomaHPV-Related Vulvar Squamous Cell Carcinoma+4 more SCG Cell Therapy Pte. Ltd. 66
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Study completedNCT03517488What this trial is testingXmAb®20717 in Subjects With Selected Advanced Solid TumorsWho this might be right forMelanomaBreast CarcinomaHepatocellular Carcinoma+25 more Xencor, Inc. 150
Testing effectiveness (Phase 2)Ended earlyNCT02837042What this trial is testingTrial of Pembrolizumab for Advanced Penile Squamous Cell CarcinomaWho this might be right forPenile Squamous Cell Carcinoma University of Alabama at Birmingham 6
Testing effectiveness (Phase 2)Study completedNCT01728233What this trial is testingDacomitinib (PF-00299804) in Advanced/Metastatic Squamous Cell Carcinoma of the PenisWho this might be right forPenile NeoplasmsCarcinoma, Squamous Cell Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 32
Not applicableStudy completedNCT02104063What this trial is testingCharacterising Metastatic Penile Cancer Using Molecular Imaging - Hybrid MRI-PET [MRI-PET]Who this might be right forSquamous Cell Carcinoma of the Penis Queen Mary University of London 78
Early research (Phase 1)Looking for participantsNCT07217171What this trial is testingA Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell CarcinomasWho this might be right forBladder CancerSquamous Cell Carcinoma of the LungEsophageal Squamous Cell Carcinoma+8 more EvolveImmune United, Inc 160
Testing effectiveness (Phase 2)Active Not RecruitingNCT02721732What this trial is testingPembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are MetastaticWho this might be right forAdvanced Malignant Solid NeoplasmCarcinoma of Unknown PrimaryMetastatic Adrenal Gland Pheochromocytoma+16 more M.D. Anderson Cancer Center 157
Testing effectiveness (Phase 2)Study completedNCT00066391What this trial is testingIrinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile CancerWho this might be right forPenile Cancer European Organisation for Research and Treatment of Cancer - EORTC
Testing effectiveness (Phase 2)Looking for participantsNCT03866382What this trial is testingTesting the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary TumorsWho this might be right forBladder AdenocarcinomaBladder Clear Cell AdenocarcinomaBladder Mixed Adenocarcinoma+42 more National Cancer Institute (NCI) 314
Testing effectiveness (Phase 2)Looking for participantsNCT06353906What this trial is testingCarboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile CancerWho this might be right forUrologic NeoplasmsUrogenital NeoplasmsMale Urogenital Diseases+3 more The Netherlands Cancer Institute 27
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Early research (Phase 1)Active Not RecruitingNCT05973487What this trial is testingA Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid TumorsWho this might be right forHead and Neck CancerCervical CancerNon-small Cell Carcinoma+18 more TScan Therapeutics, Inc. 840
Testing effectiveness (Phase 2)Study completedNCT04357873What this trial is testingEfficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different LocationsWho this might be right forSquamous Cell Lung CancerVulvar CancerPenile Cancer+3 more UNICANCER 112
Testing effectiveness (Phase 2)Looking for participantsNCT07110038What this trial is testingDEPECA-1 - A Phase II Study to Evaluate a First-line Systemic Therapy With Enfortumab Vedotin Plus Avelumab for Advanced and Metastatic Penile CarcinomaWho this might be right forPenile Squamous Cell Carcinoma (PSCC) Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 25